68462-697-30 : NDC 2026 Code

68462-697-30 : Lacosamide ( Lacosamide )

Additionally :

You can get information about “68462-697-30” NDC code in 68462-697-30 in HTML format

HTML | 68462-697-30 in TXT (Plain Text) format

TXT | 68462-697-30 in PDF (Portable Document Format)

PDF | 68462-697-30 in XML format

XML formats.

NDC Code : 68462-697-30 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "68462-697-30",
    "PackageDescription": "10 VIAL in 1 CARTON (68462-697-30)  / 20 mL in 1 VIAL (68462-697-20) ",
    "NDC11Code": "68462-0697-30",
    "ProductNDC": "68462-697",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Lacosamide",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Lacosamide",
    "DosageFormName": "INJECTION, SOLUTION",
    "RouteName": "INTRAVENOUS",
    "StartMarketingDate": "20260316",
    "EndMarketingDate": null,
    "MarketingCategoryName": "ANDA",
    "ApplicationNumber": "ANDA220268",
    "LabelerName": "GLENMARK PHARMACEUTICALS INC., USA",
    "SubstanceName": "LACOSAMIDE",
    "StrengthNumber": "10",
    "StrengthUnit": "mg/mL",
    "Pharm_Classes": "Decreased Central Nervous System Disorganized Electrical Activity [PE]",
    "DEASchedule": "CV",
    "Status": "Active",
    "LastUpdate": "2026-04-10",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20271231",
    "StartMarketingDatePackage": "20260316",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}